Novartis

Japan’s Health Ministry Files Complaint against Novartis

NovartisAccording to a latest report, the Japan's health ministry has recently filed a complaint with Tokyo prosecutors against Novartis (NOVN) AG.

Novartis is a leading company in the research and development of products to protect and improve health and well-being.

Novartis bone marrow cancer drug fulfills purpose in late-stage study

Novartis bone marrow cancer drug fulfills purpose in late-stage studyThe Swiss drugmaker Novartis said on Friday that a trial pill from Novartis to treat a sort of skeletal substance marrow disease reached its essential objective in a late-stage study.

Novartis said the pill has the possibility to turn into one of the first in another class of medications for the incurable sickness.

Novartis Wins EU Approval for Lucentis for Myopic Choroidal Neovascularization

NovartisNovartis International AG has informed that Lucentis has got European Commission approval for treatment of patients suffering from choroidal neovascularization. Swiss pharmaceutical giant has registered sales of $2.4 billion during year 2012 for Lucentis, launched by the company in 2006.

Novartis Battling Legal Fight In India over Patent Right

Novartis Battling Legal Fight In India over Patent Right Novartis is fighting a legal battle in India over a patent law. The law often described as Section 3d was formed to do away with the practice of patent monopolies on medications. The law was formed in accordance to the international trade rule.

Novartis to Fund University of Pennsylvania for Therapies against Cancer

NovartisNovartis will be setting up a new center for research at University of Pennsylvania, for which it will be granting $20 million. The center will be working to provide with an advanced bioengineered immune system that will help fight against cancer.

Drug Regulator Insists Stronger Safety Warnings for Novartis MS Drug

Drug Regulator Insists Stronger Safety Warnings for Novartis MS DrugEurope's drug regulator fears that Novartis MS Drug is being prescribed to patients with misleading safety warnings and this could terribly affect the people health in the region.

Pages

Advertisements